title: P2Y11 purinoceptor mediates the ATP-enhanced chemotactic response of rat neutrophils.
abstract: ATP and hydrolysis products of ATP like adenosine regulate the chemotaxis of neutrophils by activating purinoceptors and adenosine receptors. The present study was designed to examine exogenous ATP, activation of purinoceptors, and activation of A(3) adenosine receptor as key steps in the signal cascades that control cell orientation and migration of rat neutrophils. One or more of those steps might be potential therapeutic targets for treatment of inflammatory diseases. The chemotaxis of rat neutrophils was stimulated with N-formyl-methionyl-leucyl-phenylalanine (fMLP) and measured with an EZ-TAXIScan apparatus. The effects of apyrase, exogenous ATP, suramin (P2X and P2Y blocker), PPADS (a P2X blocker), TNP-ATP (P2X(1) and P2X(3) antagonist), and Reactive Blue 2 (a P2Y blocker) on the chemotactic response were also investigated. Rat neutrophil chemotaxis was significantly suppressed by apyrase. fMLP induced rat neutrophil chemotaxis was potentiated by ATP, blocked by suramin, not affected by PPADS or TNP-ATP, and significantly inhibited by RB-2. Western blotting showed that A(3), P2Y(2), and P2Y(11) were expressed in rat neutrophils. The chemotactic response of rat neutrophils to fMLP stimulation is potentiated by ATP via P2Y(11) purinoceptors but not P2X purinoceptors or A(3) adenosine receptor, and that the response plays a critical role in host defense and pathogenicity.
authors.affiliation: Department of Dental Pharmacology, Asahi University School of Dentistry, Mizuho-City, Gifu, Japan.
authors.forename: Feras
authors.initials: F
authors.lastname: Alkayed
authors.forename: Masanori
authors.initials: M
authors.lastname: Kashimata
authors.forename: Noriko
authors.initials: N
authors.lastname: Koyama
authors.forename: Toru
authors.initials: T
authors.lastname: Hayashi
authors.forename: Yasuo
authors.initials: Y
authors.lastname: Tamura
authors.forename: Yukio
authors.initials: Y
authors.lastname: Azuma
mesh_terms: D000255:Adenosine Triphosphate / Q000494:pharmacology* / Q000502:physiology; D000818:Animals; D002478:Cells, Cultured; D002634:Chemotaxis, Leukocyte / Q000187:drug effects* / Q000276:immunology; D008297:Male; D009240:N-Formylmethionine Leucyl-Phenylalanine / Q000276:immunology; D009504:Neutrophils / Q000276:immunology*; D051381:Rats; D017208:Rats, Wistar; D043684:Receptor, Adenosine A3 / Q000502:physiology; D058925:Receptors, Purinergic P2Y12 / Q000502:physiology*
chemical_list: D043684:Receptor, Adenosine A3; D058925:Receptors, Purinergic P2Y12; D009240:N-Formylmethionine Leucyl-Phenylalanine; D000255:Adenosine Triphosphate